SCHEMBL22104306

SCHEMBL22104306

Cc1ncc([N+](=O)[O-])n1CCOc1ccc2nc(N)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ PTK2 Q05397 1/20 0.52
▸ CA2 P00918 4/20 0.52
▸ CA9 Q16790 4/20 0.52
▸ CA1 P00915 3/20 0.52
▸ CA12 O43570 2/20 0.52
▸ GLA P06280 1/20 0.52
▸ EGFR P00533 2/20 0.51
▸ ERBB2 P04626 2/20 0.51
▸ NCF1 P14598 5/20 0.50
▸ KDR P35968 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28882681 0.90 PTK2 (0.52) LMNAKMT2APTK2CA2CA9
SCHEMBL22089506 0.89 PTK2 (0.54) LMNAKMT2APTK2CA2CA9
SCHEMBL22104534 0.87 EGFR (0.52) LMNAKMT2APTK2CA2CA9
SCHEMBL28350000 0.86 PTK2 (0.51) LMNAKMT2APTK2CA2CA9
SCHEMBL22089494 0.86 EGFR (0.52) LMNAKMT2APTK2CA2CA9
SCHEMBL22104307 0.86 EGFR (0.52) LMNAKMT2APTK2CA2CA9
SCHEMBL22089641 0.82 PTK2 (0.48) LMNAKMT2APTK2CA2CA9
SCHEMBL28350110 0.81 LMNA (0.47) LMNAKMT2APTK2CA2CA9
SCHEMBL22104537 0.78 EGFR (0.50) LMNAKMT2APTK2CA2CA9
SCHEMBL4272926 0.74 CA2 (0.60) LMNAKMT2ACA2CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020119212-A1 NITROIMIDAZOLE DERIVATIVE, PREPARATION AND USES THEREOF 诺沃斯达药业有限公司 2020-06-18 — — WO disclosed
CN-110776492-A Nitroimidazole derivative and preparation and application thereof 诺沃斯达药业有限公司 2020-02-11 — — CN disclosed
Send feedback